Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries.
Makoto KuranoDaisuke JubishiKoh OkamotoHideki HashimotoEri SakaiYoshifumi MoritaDaisuke SaigusaKuniyuki KanoJunken AokiSohei HaradaShu OkugawaKent DoiKyoji MoriyaYutaka YatomiPublished in: Journal of biomedical science (2022)
Considering the biological properties of sphingolipids and glycerophospholipids, an understanding of their urinary modulations in COVID-19 will help us to understand the mechanisms causing COVID-19-associated kidney injuries as well as general acute kidney injuries and may prompt researchers to develop laboratory tests for predicting maximum severity and/or novel reagents to suppress the renal complications of COVID-19.